Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_assertion type Assertion NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_head.
- NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_assertion description "[Recent reports have supported cyclin-dependent kinase inhibitor 2 (CDKN2, also known as MTS1, INK4, p16) at 9p21 as a candidate tumor-suppressor gene in solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_provenance.
- NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_assertion evidence source_evidence_literature NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_provenance.
- NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_assertion SIO_000772 9171998 NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_provenance.
- NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_assertion wasDerivedFrom befree-2016 NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_provenance.
- NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_assertion wasGeneratedBy ECO_0000203 NP1374006.RAVUCmB6HNjiDrVrX3KwxYEPyS9R7lyRtz0GuQXP3UIIU130_provenance.